These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8545432)

  • 1. [Osteo-articular complications of heart transplantation].
    Rozenberg S; Bourgeois P
    Presse Med; 1995 Dec; 24(38):1809-12. PubMed ID: 8545432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-induced hyperuricemia and gout.
    Lin HY; Rocher LL; McQuillan MA; Schmaltz S; Palella TD; Fox IH
    N Engl J Med; 1989 Aug; 321(5):287-92. PubMed ID: 2664517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia and gout among heart transplant recipients receiving cyclosporine.
    Burack DA; Griffith BP; Thompson ME; Kahl LE
    Am J Med; 1992 Feb; 92(2):141-6. PubMed ID: 1543197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of gout in primary care.
    Rakieh C; Conaghan PG
    Practitioner; 2011 Dec; 255(1746):17-20, 2-3. PubMed ID: 22272526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract]   [Full Text] [Related]  

  • 6. Urate oxidase in hyperuricemic heart transplant recipients treated with azathioprine.
    Ippoliti G; Negri M; Campana C; Vigano M
    Transplantation; 1997 May; 63(9):1370-1. PubMed ID: 9158039
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid-related complications in the cyclosporine era.
    Fryer JP; Granger DK; Leventhal JR; Gillingham K; Najarian JS; Matas AJ
    Clin Transplant; 1994 Jun; 8(3 Pt 1):224-9. PubMed ID: 8061360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
    Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoarticular complications of organ transplantations].
    Meys E; Delmas PD
    Rev Prat; 1994 Feb; 44(4):459-62. PubMed ID: 8184262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aseptic osteonecrosis after preventive and curative treatment with immunodepressive agents. Phenomena of rejection after renal transplantation].
    Francon F; Diaz R
    Brux Med; 1973 Oct; 53(10):581-6. PubMed ID: 4586642
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced hyperuricaemia and gout.
    Ben Salem C; Slim R; Fathallah N; Hmouda H
    Rheumatology (Oxford); 2017 May; 56(5):679-688. PubMed ID: 27498351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the immunosuppressive regimen in heart transplantation.
    Eisen H; Ross H
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S207-13. PubMed ID: 15093807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with gout can be cured in primary care.
    Rees F; Doherty M
    Practitioner; 2014 Dec; 258(1777):15-9, 2. PubMed ID: 25603588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricaemia in cyclosporin-treated patients: GFR-related effect.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1996 Jan; 11(1):153-8. PubMed ID: 8649625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.
    Eisen H
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii9-13. PubMed ID: 16815858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tophaceous gout in patients with renal transplants treated with cyclosporine A.
    Baethge BA; Work J; Landreneau MD; McDonald JC
    J Rheumatol; 1993 Apr; 20(4):718-20. PubMed ID: 8496871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive agents and bone disease in renal transplant patients with hypercalcemia.
    Sessa A; Esposito A; Iavicoli GD; Lettieri E; Dente G; Costa C; Bergallo M; Rossano R; Capuano M
    Transplant Proc; 2010 May; 42(4):1148-55. PubMed ID: 20534247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finger pad tophi.
    Chopra KF; Schneiderman P; Grossman ME
    Cutis; 1999 Oct; 64(4):233-6. PubMed ID: 10544876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.